36
Views
0
CrossRef citations to date
0
Altmetric
Special Report

Pulmonary vascular disease and optical coherence tomography imaging in patients with Fontan palliation

, , , , , , & show all
Pages 153-158 | Received 21 Dec 2023, Accepted 11 Mar 2024, Published online: 25 Mar 2024

References

  • Alsaied T, Rathod RH, Aboulhosn JA, et al. Reaching consensus for unified medical language in Fontan care. ESC Heart Fail. 2021;8(5):3894–3905. doi: 10.1002/ehf2.13294
  • Gewillig M, Brown SC, van de Bruaene A, et al. Providing a framework of principles for conceptualising the Fontan circulation. Acta Paediatr. 2020;109(4):651–658. doi: 10.1111/apa.15098
  • Perrin N, Dore A, van de Bruaene A, et al. The Fontan circulation: from ideal to failing hemodynamics and drug therapies for optimization. Can J Cardiol. 2022;38(7):1059–1071. doi: 10.1016/j.cjca.2022.04.014
  • Egbe AC, Miranda WR, Anderson JH, et al. Hemodynamic and clinical implications of impaired pulmonary vascular reserve in the fontan circulation. J Am Coll Cardiol. 2020;76(23):2755–2763. doi: 10.1016/j.jacc.2020.10.003
  • Gewillig M, Brown SC. The Fontan circulation after 45 years: update in physiology. Heart. 2016;102(14):1081–1086. doi: 10.1136/heartjnl-2015-307467
  • Nakano T, Fukae K, Sonoda H, et al. Follow-up study of pulmonary artery configuration in hypoplastic left heart syndrome. Gen Thorac Cardiovasc Surg. 2008;56(2):54–61. doi: 10.1007/s11748-007-0189-4
  • Heidendael JF, Engele LJ, Bouma BJ, et al. Coagulation and anticoagulation in Fontan patients. Can J Cardiol. 2022;38(7):1024–1035. doi: 10.1016/j.cjca.2022.01.028
  • Jahangiri M, Shore D, Kakkar V, et al. Coagulation factor abnormalities after the Fontan procedure and its modifications. J Thorac Cardiovasc Surg. 1997;113(6):989–992. discussion 992-983. doi: 10.1016/S0022-5223(97)70283-6
  • Varma C, Warr MR, Hendler AL, et al. Prevalence of “silent” pulmonary emboli in adults after the Fontan operation. J Am Coll Cardiol. 2003;41(12):2252–2258. doi: 10.1016/S0735-1097(03)00490-X
  • Grewal J, Al Hussein M, Feldstein J, et al. Evaluation of silent thrombus after the Fontan operation. Congenit Heart Dis. 2013;8(1):40–47. doi: 10.1111/j.1747-0803.2012.00699.x
  • Sughimoto K, Okauchi K, Zannino D, et al. Total cavopulmonary connection is superior to atriopulmonary connection Fontan in preventing thrombus formation: computer simulation of flow-related blood coagulation. Pediatr Cardiol. 2015;36(7):1436–1441. doi: 10.1007/s00246-015-1180-y
  • Tsang W, Johansson B, Salehian O, et al. Intracardiac thrombus in adults with the Fontan circulation. Cardiol Young. 2007;17(6):646–651. doi: 10.1017/S104795110700145X
  • Coon PD, Rychik J, Novello RT, et al. Thrombus formation after the Fontan operation. Ann Thorac Surg. 2001;71(6):1990–1994. doi: 10.1016/S0003-4975(01)02472-9
  • Balling G, Vogt M, Kaemmerer H, et al. Intracardiac thrombus formation after the Fontan operation. J Thorac Cardiovasc Surg. 2000;119(4 Pt 1):745–752. doi: 10.1016/S0022-5223(00)70010-9
  • Sathananthan G, Johal N, Verma T, et al. Clinical importance of fontan circuit thrombus in the adult population: significant association with increased risk of cardiovascular events. Can J Cardiol. 2019;35(12):1807–1814. doi: 10.1016/j.cjca.2019.08.038
  • Ishida H, Kogaki S, Ichimori H, et al. Overexpression of endothelin-1 and endothelin receptors in the pulmonary arteries of failed Fontan patients. Int J Cardiol. 2012;159(1):34–39. doi: 10.1016/j.ijcard.2011.02.021
  • Zongtao Y, Huishan W, Zengwei W, et al. Experimental study of nonpulsatile flow perfusion and structural remodeling of pulmonary microcirculation vessels. Thorac Cardiovasc Surg. 2010;58(8):468–472. doi: 10.1055/s-0030-1250124
  • Kurotobi S, Sano T, Kogaki S, et al. Bidirectional cavopulmonary shunt with right ventricular outflow patency: the impact of pulsatility on pulmonary endothelial function. J Thorac Cardiovasc Surg. 2001;121(6):1161–1168. doi: 10.1067/mtc.2001.113024
  • Henaine R, Vergnat M, Bacha EA, et al. Effects of lack of pulsatility on pulmonary endothelial function in the Fontan circulation. J Thorac Cardiovasc Surg. 2013;146(3):522–529. doi: 10.1016/j.jtcvs.2012.11.031
  • Becker K, Uebing A, Hansen JH. Pulmonary vascular disease in Fontan circulation-is there a rationale for pulmonary vasodilator therapies? Cardiovasc Diagn Ther. 2021;11(4):1111–1121. doi: 10.21037/cdt-20-431
  • Egbe AC, Reddy YNV, Khan AR, et al. Venous congestion and pulmonary vascular function in Fontan circulation: implications for prognosis and treatment. Int J Cardiol. 2018;271:312–316. doi: 10.1016/j.ijcard.2018.05.039
  • Gewillig M, Cools B, Van De Bruaene A. Pulmonary vascular reserve in Fontan patients: looking upstream for the true heart of the matter. J Am Coll Cardiol. 2020;76(23):2764–2767. doi: 10.1016/j.jacc.2020.10.006
  • Ridderbos FJ, Wolff D, Timmer A, et al. Adverse pulmonary vascular remodeling in the Fontan circulation. J Heart Lung Transplant. 2015;34(3):404–413. doi: 10.1016/j.healun.2015.01.005
  • Hays BS, Baker M, Laib A, et al. Histopathological abnormalities in the central arteries and veins of Fontan subjects. Heart. 2018;104(4):324–331. doi: 10.1136/heartjnl-2017-311838
  • Adachi I, Ueno T, Hori Y, et al. Alterations in the medial layer of the main pulmonary artery in a patient with longstanding Fontan circulation. Interact Cardiovasc Thorac Surg. 2010;11(5): 682–683. doi: 10.1510/icvts.2010.240879
  • Baumgartner H, De Backer J, Babu-Narayan SV, et al. ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2020;42(6):563–645. doi: 10.1093/eurheartj/ehaa554
  • van Melle JP, Wolff D, Horer J, et al. Surgical options after Fontan failure. Heart. 2016;102(14):1127–1133. doi: 10.1136/heartjnl-2015-309235
  • Simpson KE, Pruitt E, Kirklin JK, et al. Fontan patient survival after pediatric heart transplantation has improved in the current era. Ann Thorac Surg. 2017;103(4):1315–1320. doi: 10.1016/j.athoracsur.2016.08.110
  • Mitchell MB, Campbell DN, Ivy D, et al. Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure. J Thorac Cardiovasc Surg. 2004;128(5):693–702. doi: 10.1016/j.jtcvs.2004.07.013
  • McGovern E, Voss C, Brunner NW, et al. Pulmonary artery wall thickness in children with Fontan physiology: an optical coherence tomography case control study. Cardiol Young. 2019;29(4):524–527. doi: 10.1017/S1047951119000362
  • Bressollette E, Dupuis J, Bonan R, et al. Intravascular ultrasound assessment of pulmonary vascular disease in patients with pulmonary hypertension. Chest. 2001;120(3):809–815. doi: 10.1378/chest.120.3.809
  • Rodes-Cabau J, Domingo E, Roman A, et al. Intravascular ultrasound of the elastic pulmonary arteries: a new approach for the evaluation of primary pulmonary hypertension. Heart. 2003;89(3): 311–315. doi: 10.1136/heart.89.3.311
  • Sun L, Jiang Q, Xie Y, et al. Optical coherence tomography of the pulmonary arteries in children with congenital heart diseases: a systematic review. Pediatr Investig. 2022;6(4):264–270. doi: 10.1002/ped4.12353
  • Hayabuchi Y, Homma Y, Kagami S, et al. Optical coherence tomography for observing development of pulmonary arterial vasa vasorum after bidirectional cavopulmonary connection in children. PLoS One. 2019;14(4):e0215146. doi: 10.1371/journal.pone.0215146
  • Hayabuchi Y, Homma Y, Kagami S. Three-dimensional imaging of pulmonary arterial vasa vasorum using optical coherence tomography in patients after bidirectional Glenn and Fontan procedures. Eur Heart J Cardiovasc Imaging. 2021;22(8):941–949. doi: 10.1093/ehjci/jeaa098
  • Stout KK, Daniels CJ, Aboulhosn JA, et al. AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2018;73(12):e81–e192. doi: 10.1016/j.jacc.2018.08.1029
  • Hebert A, Mikkelsen UR, Thilen U, et al. Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (treatment with endothelin receptor antagonist in Fontan patients, a randomized, placebo-controlled, double-blind study measuring peak oxygen consumption) study. Circulation. 2014;130(23):2021–2030. doi: 10.1161/CIRCULATIONAHA.113.008441
  • Goldberg DJ, Zak V, Goldstein BH, et al. Results of the FUEL trial. Circulation. 2020;141(8):641–651. doi: 10.1161/CIRCULATIONAHA.119.044352
  • Constantine A, Dimopoulos K, Jenkins P, et al. Use of pulmonary arterial hypertension therapies in patients with a Fontan circulation: current practice across the United Kingdom. J Am Heart Assoc. 2022;11(1):e023035. doi: 10.1161/JAHA.121.023035
  • Reinhardt Z, Uzun O, Bhole V, et al. Sildenafil in the management of the failing Fontan circulation. Cardiol Young. 2010;20(5):522–525. doi: 10.1017/S1047951110000648
  • Morchi GS, Ivy DD, Duster MC, et al. Sildenafil increases systemic saturation and reduces pulmonary artery pressure in patients with failing Fontan physiology. Congenit Heart Dis. 2009;4(2):107–111. doi:10.1111/j.1747-0803.2008.00237.x
  • Agnoletti G, Gala S, Ferroni F, et al. Endothelin inhibitors lower pulmonary vascular resistance and improve functional capacity in patients with Fontan circulation. J Thorac Cardiovasc Surg. 2017;153(6):1468–1475. doi: 10.1016/j.jtcvs.2017.01.051
  • Ovaert C, Thijs D, Dewolf D, et al. The effect of bosentan in patients with a failing Fontan circulation. Cardiol Young. 2009;19(4):331–339. doi: 10.1017/S1047951109990023
  • Mongeon FP, Macle L, Beauchesne LM, et al. Non-vitamin K antagonist oral anticoagulants in adult congenital heart disease. Can J Cardiol. 2019;35(12):1686–1697. doi: 10.1016/j.cjca.2019.06.022
  • Kleier DJ, Deeg DK, Averbach RE. The extraoral approach to the infraorbital nerve block. J Am Dent Assoc. 1983;107(5):758–760. doi:10.14219/jada.archive.1983.0318
  • Li N, Zhang S, Hou J, et al. Assessment of pulmonary artery morphology by optical coherence tomography. Heart Lung Circ. 2012;21(12):778–781. doi: 10.1016/j.hlc.2012.07.014

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.